Log in
Enquire now
‌

US Patent 11384064 Chemokine receptor modulators and uses thereof

Patent 11384064 was granted and assigned to Rapt on July, 2022 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Applicant
RAPT Therapeutics
RAPT Therapeutics
Current Assignee
RAPT Therapeutics
RAPT Therapeutics
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
113840640
Patent Inventor Names
Mikhail Zibinsky0
Omar Robles-Resendiz0
Parcharee Tivitmahaisoon0
Akinori Okano0
Ashkaan Younai0
David Juergen Wustrow0
Jacob Bradley Schwarz0
Jeffrey J. Jackson0
...
Date of Patent
July 12, 2022
0
Patent Application Number
168598960
Date Filed
April 27, 2020
0
Patent Citations
‌
US Patent 10683280 Chemokine receptor modulators and uses thereof
Patent Primary Examiner
‌
Erich A Leeser
0
CPC Code
‌
C07D 401/14
0

Disclosed herein, inter alia, are compounds and methods of use thereof for the modulation of certain chemokine receptor activity.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11384064 Chemokine receptor modulators and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.